Proclara Biosciences is Biotechnology in United States that focus on systemic amyloidosis business. Founded in 2006. They cover business area such as developer, disease-modify therapy, neurodegenerative disease, multiple misfolde protein, clinician, patient, Alzheimer, Parkinson, systemic amyloidosis.
2006
( 18 years old in 2024 )
Systemic Amyloidosis
-
125 CambridgePark Drive
Suite 301
Cambridge, MA 02140
United States
Private
developerdisease-modify therapyneurodegenerative diseasemultiple misfolde proteinclinicianpatientAlzheimerParkinsonsystemic amyloidosis
* We use standard office opening hours in near Proclara Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Proclara Biosciences is Biotechnology business from United States that founded in 2006 (18 years old in 2024), Proclara Biosciences business is focusing on Systemic Amyloidosis.
Proclara Biosciences headquarter office and corporate office address is located in 125 CambridgePark Drive Suite 301 Cambridge, MA 02140 United States.
Proclara Biosciences was founded in United States.
In 2024, Proclara Biosciences is currently focus on systemic amyloidosis sector.
Above is snippet of Google Trends for "systemic amyloidosis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Proclara Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
